- Edwards Pauses Enrollments In Pivotal Mitral, Tricuspid Trials In Response To Hospitals' Focus On COVID-19
- Edwards Lifesciences To Present At The Cowen 40th Annual Healthcare Conference
- Edwards Lifesciences' Every Heartbeat Matters Philanthropic Initiative Expanding To Reach More Patients
- Edwards Lifesciences Reports Fourth Quarter Results
- Edwards Lifesciences To Host Earnings Conference Call On January 30, 2020
- Edwards Lifesciences To Present At The 38th Annual J.P. Morgan Healthcare Conference
Edwards Lifesciences Corp (EW*:MEX) closed at 4,529.80, -5.52% below its 52-week high of 4,794.52, set on Nov 27, 2019.
3,308.00Apr 29 20194,794.52Nov 27 2019
Markit short selling activity
|Market cap||41.08bn USD|
|EPS (TTM)||4.95 |
Data delayed at least 20 minutes, as of Mar 24 2020 11:30 BST.